tiprankstipranks
Advertisement
Advertisement

HK:9887 Stock Latest News

Nanjing Leads Biolabs Advances Key Immunotherapy LBL-024 in Esophageal Cancer Trial
Company AnnouncementsNanjing Leads Biolabs Advances Key Immunotherapy LBL-024 in Esophageal Cancer Trial
3d ago
9887
Nanjing Leads Biolabs’ PD-L1/4-1BB Cancer Drug Wins Priority Review in China
PremiumCompany Announcements
Nanjing Leads Biolabs’ PD-L1/4-1BB Cancer Drug Wins Priority Review in China
7d ago
9887
Leads Biolabs touts promising Phase II data for NSCLC bispecific antibody LBL-024
PremiumCompany Announcements
Leads Biolabs touts promising Phase II data for NSCLC bispecific antibody LBL-024
8d ago
9887
Oblenio Exercises License Option for Nanjing Leads Biolabs’ Autoimmune Drug LBL-051
PremiumCompany Announcements
Oblenio Exercises License Option for Nanjing Leads Biolabs’ Autoimmune Drug LBL-051
8d ago
9887
Nanjing Leads Biolabs Sets Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany Announcements
Nanjing Leads Biolabs Sets Board Meeting to Approve Interim Results and Consider Dividend
9d ago
9887
Nanjing Leads Biolabs Advances Key Liver Cancer Trial for Opamtistomig
PremiumCompany AnnouncementsNanjing Leads Biolabs Advances Key Liver Cancer Trial for Opamtistomig
23d ago
9887
Nanjing Leads Biolabs Advances Autoimmune Drug LBL-051 Into First-in-Human Trial
Premium
Company Announcements
Nanjing Leads Biolabs Advances Autoimmune Drug LBL-051 Into First-in-Human Trial
24d ago
9887
Nanjing Leads Biolabs Wins IND Nod for Bispecific Antibody in Metastatic Colorectal Cancer
Premium
Company Announcements
Nanjing Leads Biolabs Wins IND Nod for Bispecific Antibody in Metastatic Colorectal Cancer
25d ago
9887
Nanjing Leads Biolabs Completes Phase II Enrollment for Opamtistomig in Biliary Tract Cancer
PremiumCompany Announcements
Nanjing Leads Biolabs Completes Phase II Enrollment for Opamtistomig in Biliary Tract Cancer
29d ago
9887
Nanjing Leads Biolabs CEO Extends Lock-Up, Signaling Confidence in Long-Term Prospects
PremiumCompany Announcements
Nanjing Leads Biolabs CEO Extends Lock-Up, Signaling Confidence in Long-Term Prospects
1M ago
9887
Nanjing Leads Biolabs Wins Key ESMO Slots as Flagship Immunotherapy Assets Gain Momentum
PremiumCompany Announcements
Nanjing Leads Biolabs Wins Key ESMO Slots as Flagship Immunotherapy Assets Gain Momentum
2M ago
9887
Nanjing Leads Biolabs’ LBL-024 for EP-NEC Enters China Priority Review
PremiumCompany Announcements
Nanjing Leads Biolabs’ LBL-024 for EP-NEC Enters China Priority Review
2M ago
9887
Nanjing Leads Biolabs Grants Over 2.25 Million H Share Awards to Staff Under Incentive Scheme
PremiumCompany AnnouncementsNanjing Leads Biolabs Grants Over 2.25 Million H Share Awards to Staff Under Incentive Scheme
2M ago
9887
Nanjing Leads Biolabs’ JV Secures US$62 Million to Advance Trispecific Autoimmune Therapy
Premium
Company Announcements
Nanjing Leads Biolabs’ JV Secures US$62 Million to Advance Trispecific Autoimmune Therapy
2M ago
9887
Nanjing Leads Biolabs Completes H Share Full Circulation to Boost Liquidity
Premium
Company Announcements
Nanjing Leads Biolabs Completes H Share Full Circulation to Boost Liquidity
3M ago
9887
Nanjing Leads Biolabs Showcases Promising Opamtistomig Data Ahead of 2026 Lung Cancer Summit
PremiumCompany Announcements
Nanjing Leads Biolabs Showcases Promising Opamtistomig Data Ahead of 2026 Lung Cancer Summit
3M ago
9887
Nanjing Leads Biolabs Plans Up to US$50 Million H-Share Purchases for Employee Award Scheme
PremiumCompany Announcements
Nanjing Leads Biolabs Plans Up to US$50 Million H-Share Purchases for Employee Award Scheme
3M ago
9887
Nanjing Leads Biolabs Wins Phase III Green Light for Key Cancer Drug Opamtistomig
PremiumCompany Announcements
Nanjing Leads Biolabs Wins Phase III Green Light for Key Cancer Drug Opamtistomig
3M ago
9887
Nanjing Leads Biolabs Shareholders Approve All AGM Resolutions, Expand Board Mandates
PremiumCompany Announcements
Nanjing Leads Biolabs Shareholders Approve All AGM Resolutions, Expand Board Mandates
4M ago
9887
Nanjing Leads Biolabs Sets Out Board Line-Up and Committee Roles
PremiumCompany AnnouncementsNanjing Leads Biolabs Sets Out Board Line-Up and Committee Roles
4M ago
9887
Nanjing Leads Biolabs Wins HKEX Approval for H-Share Full Circulation
Premium
Company Announcements
Nanjing Leads Biolabs Wins HKEX Approval for H-Share Full Circulation
4M ago
9887
Nanjing Leads Biolabs Advances H Share Full Circulation After CSRC Filing Notice
Premium
Company Announcements
Nanjing Leads Biolabs Advances H Share Full Circulation After CSRC Filing Notice
4M ago
9887

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >